Advertisement

Topics

STAT Plus: Is the FDA telegraphing a rejection for PTC Therapeutics’ DMD drug?

13:05 EDT 1 Aug 2017 | STAT

An internal memo suggests the FDA made a one-time exception to approve Sarepta's DMD drug despite weak evidence and won't look kindly on PTC's application.

Original Article: STAT Plus: Is the FDA telegraphing a rejection for PTC Therapeutics’ DMD drug?

NEXT ARTICLE

More From BioPortfolio on "STAT Plus: Is the FDA telegraphing a rejection for PTC Therapeutics’ DMD drug?"

Quick Search
Advertisement
 

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...